The mechanisms by which ethanol damages the developing and adult central nervous system (CNS) remain unclear. Activitydependent neuroprotective protein (ADNP) is a glial protein that protects the CNS against a wide array of insults and is critical for CNS development. NAPVSIPQ (NAP), a potent active fragment of ADNP, potentiated axon outgrowth in cerebellar granule neurons by activating the sequential tyrosine phosphorylation of Fyn kinase and the scaffold protein Crk-associated substrate (Cas). Pharmacological inhibition of Fyn kinase or expression of a Fyn kinase siRNA abolished NAP-mediated axon outgrowth. Concentrations of ethanol attained after social drinking blocked NAP-mediated axon outgrowth (IC 50 ‫؍‬ 17 mM) by inhibiting NAP activation of Fyn kinase and Cas. These findings identify a mechanism for ADNP regulation of glial-neuronal interactions in developing cerebellum and a pathogenesis of ethanol neurotoxicity.
A lcohol exposure during pregnancy causes growth retardation, birth defects, and neurodevelopmental abnormalities, referred to as fetal alcohol spectrum disorder (FASD). Children with FASD show a spectrum of developmental abnormalities in different brain regions; among these, the cerebellum is particularly affected (1, 2) . The prevention and treatment of FASD require a thorough understanding of its pathophysiology; however, the mechanisms underlying ethanol's developmental neurotoxicity remain unclear.
Prenatal ethanol exposure causes disordered neuronal migration, disruption of axonal and dendritic connectivity, death of neuronal and glial progenitors, and neuronal apoptosis (3) (4) (5) . Numerous mechanisms of ethanol-induced neuronal death have been identified; however, one potentially important mechanism has not been sufficiently explored: cell death triggered by axonal injury. Axonal injury is sometimes an early event in neuronal death, and differential axon vulnerability might account for the region-specific damage observed in diverse neurological disorders (6) , including those associated with alcoholism. Indeed, ethanol has been observed to inhibit neurite outgrowth before causing neuronal death (7) .
The development of neuronal processes is regulated by a variety of molecular cues (8) , many of which are derived from glial cells. Hence, ethanol might damage axons by disrupting the regulation of neuronal differentiation by glial-derived molecules. One such molecule is particularly worthy of study. Activitydependent neuroprotective protein (ADNP) is an astrocytederived protein that is essential for brain development (9) (10) (11) . ADNP is highly expressed in cerebellum, a brain region that is selectively vulnerable to ethanol toxicity during development and adult life (1, 12) . The octapeptide NAPVSIPQ (NAP), an active fragment of ADNP, has been shown to potently protect the nervous system against a wide range of insults (11) , including prenatal alcohol exposure (13) . More recently, NAP has been shown to promote neurite outgrowth in several types of cultured neurons (11, 14) through mechanisms that are incompletely understood. To learn whether ethanol disrupts ADNP-stimulated neuronal differentiation, we first established that NAP stimulates axon outgrowth in cerebellar granule neurons (CGNs) and characterized the underlying signaling pathways. We then asked whether ethanol blocks NAP-mediated axon outgrowth by disrupting NAP signaling.
Results

Effects of NAP on Axon Outgrowth in Cerebellar Granule Neurons.
Although NAP has been shown to stimulate neurite outgrowth in a variety of cultured neurons, the effects of NAP on cerebellar neurons have not been investigated. Postnatal day 7 (PD7) rat CGNs were cultured for 20 h in serum-free medium supplemented with a range of concentrations of NAP ( Fig. 1 ). At this time point, the majority (Ͼ95%) of CGNs gave rise to a single long process that stained positively with Tau-1 antibodies, identifying the process as an axon (15) . NAP induced a bimodal, dose-dependent increase in axon length ( Fig. 1 ) over a broad range of concentrations. The first limb of the dose-response curve showed a significant initial response at 10 Ϫ18 M and a maximal increase in axon outgrowth of 64.8% at 10 Ϫ12 M. The second limb showed a peak response at 10 Ϫ9 M and a progressive decline at concentrations Ͼ10 Ϫ8 M (Fig. 1B) .
Signal Transduction Molecules Implicated in NAP-Mediated Axon
Outgrowth. To determine the molecular mechanisms by which NAP potentiates axon outgrowth, we cultured CGNs in the absence and presence of NAP and concentrations of kinase inhibitors that selectively inhibit signal transduction in CGNs (16) . None of the inhibitors significantly affected axon outgrowth in the absence of NAP (Fig. 2 ). NAP potentiation of axon outgrowth was abolished by 5 M 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d] pyrimidine (PP2), an inhibitor of Src family kinases (SFKs) (17), but was not affected by 5 M 4-amino-7-phenylpyrazol[3,4-d]pyrimidine (PP3), an inactive analog of PP2. NAP potentiation of axon outgrowth was significantly reduced by 10 M 2Ј-amino-3Ј-methoxyf lavone (PD98059), an inhibitor of mitogen-activated protein kinase kinase (MEK), but not by 100 M adenosine 3Ј,5Ј-cyclic phosphorothioate-Rp isomer (Rp-cAMP), an inhibitor of protein kinase A (PKA), or cytochalasin D (100 nM), an inhibitor of F-actin polymerization. These data suggest that a SFK is a major intracellular mediator of NAP-stimulated axon outgrowth in CGNs, although other pathways may also be important.
Knockdown of Fyn Kinase Expression Abolishes NAP-Mediated Axon
Outgrowth. Tyrosine phosphorylation of Fyn kinase at Y416 is required for ligand induction of axon outgrowth in cortical neurons (18) . To determine whether Fyn kinase is necessary for NAP-mediated axon outgrowth, we used Fyn siRNA coupled to a YFP reporter (Fyn siRNA-YFP) to knock down the expression of Fyn in CGNs. Fyn kinase expression and axon outgrowth were analyzed 48 h after transfection. Individual CGNs that expressed Fyn siRNA-YFP showed nearly absent immunostaining with an anti-Fyn kinase antibody ( transfected with YFP alone showed normal levels of Fyn kinase ( Fig. S1, arrowhead) .
Axons associated with YFP-expressing and Fyn siRNA-YFPexpressing CGNs were identified by comparing bright-field and fluorescence images from the same cells. Axon length was then quantified from the bright-field images. Transfection of CGNs with Fyn siRNA-YFP or YFP had no significant effect on basal axon outgrowth ( Fig. 3 ). Treatment with 10 Ϫ12 M NAP produced a robust increase in axon outgrowth in WT and YFP-transfected CGNs, but had no effect in Fyn kinase siRNA-YFP-transfected CGNs (Fig. 3) . These results indicate that Fyn kinase is necessary for NAP-mediated axon outgrowth in CGNs.
NAP Activates Fyn Kinase.
To determine whether NAP activates Fyn kinase, we measured Y416 phosphorylation in immunoprecipitates of Fyn kinase from control and NAP-treated CGNs. Incubation of CGNs for 10 min with 10 Ϫ12 M NAP caused a significant increase in Y416 phosphorylation of Fyn kinase ( Fig. 4 ). Levels of Y416 phosphorylation remained significantly increased 30 min after NAP treatment and declined to control levels by 2 h ( Fig. 4 A and B) . NAP-induced Y416 phosphorylation of Fyn kinase was inhibited by PP2, but not by PP3 (Fig. 4C ). These results indicate that NAP activates Fyn kinase in CGNs.
NAP Activation of Fyn Kinase Leads to Phosphorylation of Crk-
Associated Substrate (Cas). Fyn kinase induces tyrosine phosphorylation of Cas, a scaffold protein that links Fyn kinase signaling to axon elongation in CGNs (19) . Therefore, we asked whether NAP potentiation of axon outgrowth is associated with increased phosphorylation of Cas. CGNs were treated with 10 Ϫ12 M NAP for varying lengths of time and cell lysates were immunoblotted with an antibody against pY410Cas. Phosphorylation of Cas increased within 10 min of NAP treatment, was sustained at 30 min, and decreased to control levels by 2 h (Fig. 5A and B) , a time course similar to that observed for NAP activation of Fyn kinase ( Fig. 4) . Indeed, NAP activation of Cas phosphorylation was eliminated after treatment with PP2, but not PP3 (Fig. 5C ). These data suggest that NAP induces the phosphorylation of Cas through the activation of Fyn kinase.
We also asked whether activated Cas and Fyn are physically associated in NAP-treated CGNs. Cell lysates from CGNs were immunoprecipitated with a Fyn antibody and immunoblotted with an antibody against pY410Cas. Treatment with 10 Ϫ12 M NAP increased levels of phosphorylated Cas in Fyn antibody immunoprecipitates, and PP2 blocked this effect of NAP (Fig.  5D ). These results indicate that activated Cas and activated Fyn kinase are physically associated in NAP-treated CGNs.
Ethanol Inhibits NAP-Mediated Axon Outgrowth.
To test the hypothesis that ethanol disrupts the actions of ADNP, we determined the effects of ethanol on NAP-mediated axon outgrowth. CGNs were incubated for 20 h with 10 Ϫ12 M NAP in the absence and presence of increasing concentrations of ethanol. Ethanol alone had no significant effect on basal levels of axon outgrowth (Fig.  6A ). In contrast, ethanol caused a dose-dependent reduction in NAP-mediated axon outgrowth, with significant effects at concentrations as low as 10 mM and half-maximal inhibition at a concentration of 17 mM (Fig. 6B ). These findings demonstrate that concentrations of ethanol attained during moderate drinking reduce NAP-mediated axon outgrowth in developing CGNs.
Ethanol Inhibits NAP Activation of Fyn Kinase and Phosphorylation of
Cas. We next asked whether ethanol decreases NAP-mediated axon outgrowth by disrupting NAP activation of Fyn kinase and Cas. CGNs were incubated for 30 min with 10 Ϫ12 M NAP in the absence and presence of 25 mM ethanol. Ethanol alone did not significantly increase Y416 phosphorylation in Fyn kinase ( Fig.  7 A and B) and Cas phosphorylation at Y410 ( Fig. 7 C and D) . However, ethanol significantly decreased NAP-induced phosphorylation of Fyn kinase (101.5 Ϯ 19.5% reduction; n ϭ 4; P Ͻ 0.05) and Cas (107.0 Ϯ 16.9% reduction; n ϭ 4; P Ͻ 0.01) ( Fig.  7) . Taken together, these data demonstrate that ethanol inhibits NAP-mediated axon outgrowth in CGNs by blocking NAP activation of the Fyn kinase-Cas signaling pathway.
Discussion
The major finding of this article is that ethanol inhibits axon outgrowth in CGNs by disrupting NAP activation of SFK signaling. We used NAP, an extremely potent octapeptide fragment of ADNP, to model ADNP signaling and function. Subfemtomolar concentrations of NAP stimulated axon outgrowth in CGNs through the sequential activation of Fyn kinase and the scaffold protein Cas. Importantly, ethanol blocked this NAP signaling pathway and inhibited NAP-mediated axon outgrowth at concentrations that are readily attained during social drinking. Our findings suggest that ethanol might cause FASD partly by disrupting the actions of ADNP that support the differentiation and survival of CGNs. ADNP is a glial-derived protein that is critical for brain development. In mouse, ADNP mRNA is expressed during embryogenesis, peaks during neural tube closure, and persists into adulthood, with the highest levels in cerebellum and hippocampus (9, 20) . In adult human brain, ADNP expression is greatest in cerebellum and cerebral cortex (21) . Deletion of the mouse ADNP gene results in failure of closure of the neural tube and death by embryonic days 8.5-9 (10). Hence intermittent disruption of ADNP signaling by ethanol could significantly disrupt brain development.
Recent studies have explored the mechanisms by which ADNP regulates brain development. NAP causes a concentrationdependent stimulation of neurite outgrowth in hippocampal, cortical, and retinal ganglion neurons and in PC-12 pheochromocytoma cells (14, (22) (23) (24) . NAP binds tubulin and facilitates microtubule assembly in astrocytes (25) and stimulates AKT, MAPK, and adenylate cyclase in cortical neurons (14) . NAP also increases the polyADP-ribosylation of histone H1 in PC12 cells, and inhibitors of PARP-1 diminished NAP-induced neurite outgrowth (24) .
Our study examined the effects of NAP on axon outgrowth in neurons derived from the cerebellum, the brain region richest in ADNP. Our findings establish that NAP activation of Fyn kinase is necessary for NAP potentiation of axon outgrowth in CGNs. Axon outgrowth was abolished by PP2, an SFK inhibitor, or by transfection with a Fyn kinase siRNA. NAP potentiation of axon outgrowth was partially reduced by inhibitors of MAPK, suggesting that additional signaling pathways contribute to the actions of NAP. Consistent with this observation, Pascual and Guerri (14) recently reported that inhibitors of MAPK and PI3-kinase/AKT reduced NAP-mediated increases in MAP-2 staining in cortical neurons. It remains to be determined whether MAPK is activated upstream or downstream of Fyn kinase and Cas.
Fyn kinase is a member of the Src family of nonreceptor tyrosine kinases. Fyn kinase is developmentally regulated and is highly expressed in the growth cones and axons of cerebellar neurons. Fyn kinase is necessary for axon outgrowth stimulated by diverse axon guidance molecules, including neural cell adhesion molecule, prion protein, semaphorin-3A, contactin, glial cell line-derived neurotrophic factor, and netrin-1 (18, 26 -30) . Our results indicate that ADNP is a member of the family of molecules that regulate axon outgrowth by activating Fyn kinase. Because neuronal differentiation and axon guidance are important components of normal brain development, activation of Fyn kinase by ADNP may contribute to its critical role in development.
The scaffold protein Cas plays an essential role in intracellular signaling events by coordinating the interaction of multiple cellular proteins involved in cell adhesion, migration, proliferation, and survival (31) . Cas is enriched in the cerebellum and is colocalized with Fyn kinase. Cas is concentrated in neurites and growth cones and is required for axon extension in CGNs (19) and netrin-mediated commissural axon guidance (32) . Our results demonstrate that NAP potentiates axon outgrowth in CGNs by the sequential activation of Fyn kinase and Cas, suggesting that ADNP might regulate neuronal differentiation by activating this signal transduction pathway. NAP-mediated axon outgrowth was particularly sensitive to ethanol, with significant inhibition occurring at concentrations attained after only 1 or 2 drinks. Our studies indicate that ethanol inhibits NAP activation of Fyn kinase and Cas, 2 critical signaling events in NAP-mediated axon outgrowth. These observations suggest that ethanol might disrupt neuronal differentiation partly by blocking ADNP signaling. Interestingly, prenatal ethanol exposure decreased the expression of ADNP mRNA in cerebral cortex and astrocytes and reduced astrocyte induction of neurite outgrowth and synaptogenesis in cortical neurons (14) . Hence, ethanol may disrupt brain development by disrupting both the expression and signaling of ADNP. Because ADNP is expressed in the adult nervous system, ethanol disruption of ADNP signaling might also contribute to alcoholic cerebellar degeneration, a common disorder in alcoholics.
NAP is protective against a variety of brain insults, including prenatal ethanol exposure (13, 33) . We showed previously that NAP antagonizes ethanol inhibition of L1 adhesion and prevents ethanol teratogenesis in mouse embryos (33, 34) . Whereas NAP effectively antagonizes some actions of ethanol, particularly during embryogenesis, our current data indicate that ethanol also blocks some actions of NAP, at least during the period of brain growth and neuronal differentiation. Our findings provide insights into the pathophysiology of FASD and clarify the potential role for NAP as a therapeutic agent for preventing FASD.
Materials and Methods
Reagents and Animals. NAP was purchased from New England Peptides. For other reagents see SI Text. All animal procedures in this report were approved by the Animal Care and Use Committee of the Veterans Affairs Boston Healthcare System and were conducted in agreement with the Guide for the Care and Use of Laboratory Animals, National Research Council.
Cell Culture and Axon Outgrowth Assay. CGNs were prepared from the cerebellum of 6-to 7-day-old rats and cultured as described (35) (see SI Text). NAP, ethanol, and/or inhibitors of signal transduction pathways were added to culture medium 2 h after cell plating. For quantification of axon outgrowth, CGNs were cultured for 20 h, fixed with 4% paraformaldehyde and stained with toluidine blue to visualize cells and axons. Axon length was measured with Openlab software (Improvision). In each experiment, at least 25 cells in each of 3 wells were analyzed.
Knockdown of Fyn Kinase Expression in CGNs with siRNA.
Plasmid pSUPER Fyn siRNA-YFP and the control plasmid pSUPER YFP were generously provided by H. Colognato (State University of New York, Stony Brook). The following target sequence was used as Fyn siRNA: 5Ј-GCAGGACAGAAGATGACCT-3Ј. The introduction of Fyn kinase siRNA to CGNs was achieved by nucleofection using Nucleofector and the Rat Neuron Nucleofector Kit (Amaxa) with modification of the manufacturer's instructions and published procedures (36, 37) . In brief, 5 ϫ 10 6 CGNs in a freshly prepared, dissociated suspension were mixed with 3 g of plasmid DNA and electroporated with program G-13 using the Nucleofector device. The nucleofected cells were plated in RPMI medium 1640 containing 10% horse serum; the medium was replaced with serum-free medium (SI Text) 4 -6 h after plating. The transfection efficiency was evaluated based on the expression of YFP. NAP was added to the treatment groups 20 h after transfection. Forty-eight hours after transfection, cells were processed for Fyn kinase immunostaining to verify the reduction in Fyn kinase expression and to measure axon outgrowth. Total levels of Fyn kinase were determined from lysates of CGNs by immunoblotting with a Fyn kinase mAb.
Immunostaining. CGNs cultured on glass coverslips were fixed with 4% paraformaldehyde for 30 min, permeabilized with cold methanol for 5 min, blocked with 3% BSA, and incubated with anti-Fyn kinase antibody followed by Cy3-conjugated secondary antibody. Nuclei were visualized with Hoechst dye. Images were acquired with a Nikon fluorescence microscope using a digital camera (Hamamatsu; model C4742-95) and imaging software (OpenLab).
Immunoprecipitation and Immunoblotting.
Immunoprecipitation was performed by using cell lysates from CGNs and an anti-Fyn kinase polyclonal antibody as described (SI Text). Immunoprecipitated proteins were separated with 4 -15% gradient SDS/PAGE, transferred to nitrocellulose membranes, and probed with the following antibodies: rabbit anti-phospho-Src family (Tyr-416) to measure phospho-Fyn kinase; mouse monoclonal anti-Fyn kinase antibody to measure total Fyn kinase, and an anti-phospho-Cas (Tyr-410) antibody to measure phospho-Cas. Whole-cell lysates were subjected to immunoblotting by using antibodies against phospho-Cas and total Cas. The densitometric analysis of Western blots was performed with TINA Image software (version 2.0).
Statistical Analysis.
Data are presented as the mean Ϯ SEM from at least 3 independent experiments performed in triplicate in axon outgrowth studies and at least 3 independent experiments in quantification of images of Western blot analysis. Statistical analysis of the data was performed by using ANOVA and the Tukey test for post hoc comparisons of means.
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Reagents. All cell culture media and supplement components were from Invitrogen. Mouse anti-Fyn mAb and mouse anti-Cas mAb were from BD Bioscience. Rabbit anti-Fyn polyclonal antibody and protein A/G agarose were from Santa Cruz Biotechnology. Rabbit anti-phospho-Src family (Y416) antibody and anti-phospho-Cas (Y410) antibody were from Cell Signaling. Mouse anti-Tau-1 mAb, anti-actin mAb, and ReBlot plus antibody stripping solution were from Chemicon. Src family kinase inhibitor PP2 and its analog PP3, protein kinase A inhibitor Rp-cAMP, MAPK inhibitor PD98059, and actin polymerization inhibitor cytochalasin D were from Calbiochem. Proteinase inhibitor mixture was from Roche. Halt phosphatase inhibitors mixture was from Pierce. Rat neuron nucleofector kit and the Nucleofector device were from Amaxa. Ethanol and all of the other reagents were obtained from Sigma-Aldrich.
Culture of CGNs. The cerebellum was excised from 6-to 7-day-old rats. The cerebella were cut into small pieces, incubated in 1% trypsin/0.05% DNase for 15 min at room temperature, washed with HBSS, and resuspended in a 0.05% DNase solution. Cells were dissociated by mechanical trituration, placed on the top of a 15% FCS cushion, and centrifuged at 300ϫg to isolate CGNs. Cells were washed sequentially with HBSS and culture medium before plating. Cells were plated on poly-L-lysine (PLL)-coated culture plates and maintained in Neurobasal serum-free medium with 2 mM L-glutamine, 1 mg/ml BSA, 12.5 g/ml insulin, 4 nM thyroxine, 100 g/ml transferrin, and 30 nM sodium selenite.
Cell Lysate Preparation and Immunoprecipitation. CGNs were incubated for various durations in the absence or presence of NAP (10 Ϫ12 M), ethanol (100 mM), PP2, or PP3. Cells were washed with ice-cold PBS and lysed on ice for 30 min in 20 mM Tris⅐HCl (pH 7.5), 150 mM NaCl, 5 mm EDTA, and 1% Triton X-100 with cocktails of proteinase inhibitors and phosphatase inhibitors, and centrifuged at 16,000ϫg for 20 min. The protein concentration in the supernatant was determined by the bicinchinonic acid method. For immunoprecipitation of Fyn kinase, 300 g of cell lysates was incubated overnight at 4°C with rabbit anti-Fyn antibody and protein A/G-agarose beads. The immunoprecipitates were boiled in SDS sample buffer for 5 min and processed for immunoblot analysis of levels of phosphorylated Fyn kinase, total Fyn kinase, and phosphorylated Cas. 
